These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2919850)

  • 21. Hypogonadism and sexual dysfunction in hemochromatosis: the effects of cirrhosis and diabetes.
    Cundy T; Bomford A; Butler J; Wheeler M; Williams R
    J Clin Endocrinol Metab; 1989 Jul; 69(1):110-6. PubMed ID: 2732293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of hypogonadism and associated impaired metabolic and bone mineral status in subfertile men.
    Bobjer J; Bogefors K; Isaksson S; Leijonhufvud I; Åkesson K; Giwercman YL; Giwercman A
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):189-95. PubMed ID: 26857217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic role of androgens in the treatment of osteoporosis in men.
    Katznelson L
    Baillieres Clin Endocrinol Metab; 1998 Oct; 12(3):453-70. PubMed ID: 10332566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic or hypogonadal osteoporosis in men: current and future treatment options.
    Ebeling PR
    Treat Endocrinol; 2004; 3(6):381-91. PubMed ID: 15511132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone involvement in primary hemochromatosis and alcoholic cirrhosis.
    Conte D; Caraceni MP; Duriez J; Mandelli C; Corghi E; Cesana M; Ortolani S; Bianchi PA
    Am J Gastroenterol; 1989 Oct; 84(10):1231-4. PubMed ID: 2801672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis in men with hyperprolactinemic hypogonadism.
    Greenspan SL; Neer RM; Ridgway EC; Klibanski A
    Ann Intern Med; 1986 Jun; 104(6):777-82. PubMed ID: 3706929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary hypogonadism in hemochromatosis.
    Meyer WR; Hutchinson-Williams KA; Jones EE; DeCherney AH
    Fertil Steril; 1990 Oct; 54(4):740-2. PubMed ID: 2209900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study.
    Szulc P; Claustrat B; Marchand F; Delmas PD
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5240-7. PubMed ID: 14602756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.
    Finkelstein JS; Klibanski A; Neer RM; Doppelt SH; Rosenthal DI; Segre GV; Crowley WF
    J Clin Endocrinol Metab; 1989 Oct; 69(4):776-83. PubMed ID: 2674186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversibility of hypogonadotropic hypogonadism in a patient with the juvenile form of hemochromatosis.
    Angelopoulos NG; Goula A; Dimitriou E; Tolis G
    Fertil Steril; 2005 Dec; 84(6):1744. PubMed ID: 16359978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism.
    Jackson JA; Kleerekoper M; Parfitt AM
    Ann Intern Med; 1986 Oct; 105(4):543-5. PubMed ID: 3752759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of testosterone on osteoporosis in men.
    Francis RM
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):411-4. PubMed ID: 10468898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs.
    Mittan D; Lee S; Miller E; Perez RC; Basler JW; Bruder JM
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3656-61. PubMed ID: 12161491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in the prevalence and severity of bone disease in thalassaemia.
    Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoporotic fractures: an unusual presentation of haemochromatosis.
    Eyres KS; McCloskey EV; Fern ED; Rogers S; Beneton M; Aaron JE; Kanis JA
    Bone; 1992; 13(6):431-3. PubMed ID: 1476821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Idiopathic hemochromatosis].
    Marin MG
    Minerva Med; 1985 Mar; 76(13):627-34. PubMed ID: 2986052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe osteoporosis in men.
    Kelepouris N; Harper KD; Gannon F; Kaplan FS; Haddad JG
    Ann Intern Med; 1995 Sep; 123(6):452-60. PubMed ID: 7639446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.
    Anderson FH; Francis RM; Peaston RT; Wastell HJ
    J Bone Miner Res; 1997 Mar; 12(3):472-8. PubMed ID: 9076591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study.
    Amin S; Zhang Y; Sawin CT; Evans SR; Hannan MT; Kiel DP; Wilson PW; Felson DT
    Ann Intern Med; 2000 Dec; 133(12):951-63. PubMed ID: 11119396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.